Daniel Shin

7PUBLICATIONS
88CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 13, 2026
Plasma Exchange and Daratumumab for Myeloma Cast Nephropathy.

|Jun 18, 2026
Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

|Apr 30, 2024
Enhanced CTLA-4 blockade anti-tumor immunity with APG-157 combination in a murine head and neck cancer.

Daniel Sanghoon Shin, Saroj Basak, Mysore S Veena

|Feb 29, 2024
Gigaxonin Suppresses Epithelial-to-Mesenchymal Transition of Human Cancer Through Downregulation of Snail.

Mysore S Veena, Jungmo J Gahng, Mustafa Alani

|Jun 28, 2023
Dysregulation of SWI/SNF Chromatin Remodelers in NSCLC: Its Influence on Cancer Therapies including Immunotherapy.

Yijiang Shi, Daniel Sanghoon Shin

|Oct 15, 2020
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma.

Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi

Pageof 2

Frequent Collaborators

1 joint publications

Mysore S Veena

1 joint publications

Jungmo J Gahng

1 joint publications

Mustafa Alani

1 joint publications

Albert Y Ko